IDEAS home Printed from https://ideas.repec.org/a/nat/nature/v399y1999i6738d10.1038_21658.html
   My bibliography  Save this article

Characterization of the human cysteinyl leukotriene CysLT1 receptor

Author

Listed:
  • Kevin R. Lynch

    (University of Virginia Health Sciences Center)

  • Gary P. O'Neill

    (Department of Biochemistry and Molecular Biology)

  • Qingyun Liu

    (Merck & Co.)

  • Dong-Soon Im

    (University of Virginia Health Sciences Center)

  • Nicole Sawyer

    (Department of Biochemistry and Molecular Biology)

  • Kathleen M. Metters

    (Department of Biochemistry and Molecular Biology)

  • Nathalie Coulombe

    (Department of Biochemistry and Molecular Biology)

  • Mark Abramovitz

    (Department of Biochemistry and Molecular Biology)

  • David J. Figueroa

    (Merck & Co.)

  • Zhizhen Zeng

    (Merck & Co.)

  • Brett M. Connolly

    (Merck & Co.)

  • Chang Bai

    (Merck & Co.)

  • Christopher P. Austin

    (Merck & Co.)

  • Anne Chateauneuf

    (Department of Biochemistry and Molecular Biology)

  • Rino Stocco

    (Department of Biochemistry and Molecular Biology)

  • Gillian M. Greig

    (Department of Biochemistry and Molecular Biology)

  • Stacia Kargman

    (Department of Biochemistry and Molecular Biology)

  • Shelley B. Hooks

    (University of Virginia Health Sciences Center)

  • Elizabeth Hosfield

    (University of Virginia Health Sciences Center)

  • David L. Williams

    (Department of Pharmacology)

  • Anthony W. Ford-Hutchinson

    (Department of Pharmacology)

  • C. Thomas Caskey

    (Merck & Co.)

  • Jilly F. Evans

    (Merck & Co.)

Abstract

The cysteinyl leukotrienes—leukotriene C4(LTC4), leukotriene D4(LTD4) and leukotriene E4(LTE4)—are important mediators of human bronchial asthma1,2,3,. Pharmacological studies have determined that cysteinyl leukotrienes activate at least two receptors, designated CysLT1 and CysLT2 (refs 4,5,6). The CysLT1-selective antagonists, such as montelukast (Singulair)7,8,9,10, zafirlukast (Accolate)11 and pranlukast (Onon)12, are important in the treatment of asthma. Previous biochemical characterization of CysLT1 antagonists and the CysLT1 receptor has been in membrane preparations from tissues enriched for this receptor13. Here we report the molecular and pharmacological characterization of the cloned human CysLT1 receptor. We describe the functional activation (calcium mobilization) of this receptor by LTD4 and LTC4, and competition for radiolabelled LTD4 binding to this receptor by the cysteinyl leukotrienes and three structurally distinct classes of CysLT1-receptor antagonists. We detected CysLT1-receptor messenger RNA in spleen, peripheral blood leukocytes and lung. In normal human lung, expression of the CysLT1-receptor mRNA was confined to smooth muscle cells and tissue macrophages. Finally, we mapped the human CysLT1-receptor gene to the X chromosome.

Suggested Citation

  • Kevin R. Lynch & Gary P. O'Neill & Qingyun Liu & Dong-Soon Im & Nicole Sawyer & Kathleen M. Metters & Nathalie Coulombe & Mark Abramovitz & David J. Figueroa & Zhizhen Zeng & Brett M. Connolly & Chang, 1999. "Characterization of the human cysteinyl leukotriene CysLT1 receptor," Nature, Nature, vol. 399(6738), pages 789-793, June.
    • Handle: RePEc:nat:nature:v:399:y:1999:i:6738:d:10.1038_21658
    DOI: 10.1038/21658
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/21658
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.
    File URL: https://libkey.io/10.1038/21658?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:399:y:1999:i:6738:d:10.1038_21658. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.